American Journal of Therapeutics | 21 June 2021
“Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”
AJT Ivermectin
Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248252/